Adisyn (ASX:AI1) hits 29c target as Raval MOU opens defence upside

Adisyn has hit our 29c price target, but we think the story may still have room to run

Adisyn Ltd’s (ASX:AI1) subsidiary, 2D Radar Absorbers Ltd, has signed an MOU with Raval A.C.S. Ltd, one of Israel’s largest plastics groups, to co-develop graphene-enhanced injection-moulded parts for radar absorption in drones and UAVs.

For investors, this is an important development because it moves Adisyn’s graphene stealth technology closer to a real commercial pathway.

Raval is not just another early-stage partner. It is deeply embedded in advanced component manufacturing, generating €201 million in revenue and €33 million in EBITDA in CY2025, with a €1.243 billion order backlog and 11 global facilities supplying Volkswagen, BMW, Mercedes, GM and Porsche.

That matters because Raval brings Adisyn into a manufacturing network that already understands high-volume production, strict quality control and global customer requirements.

This is what separates the announcement from a typical research collaboration.

The key point is not just that Adisyn has signed an MOU. It is where the development work will actually take place. Rather than testing the material in a lab first and then trying to adapt those results to a commercial manufacturing environment later, Adisyn and Raval plan to conduct development on Raval’s serial production machines from day one.

That is important because it removes one of the biggest risks in advanced materials commercialisation.

Parts are being designed for manufacturability from the outset. In simple terms, Adisyn is not just trying to prove the material works. It is trying to prove the material can be manufactured at scale.

That could compress the transition from prototype to volume production from years to months, assuming the technical milestones are met.

The commercial pathway is staged over 18 months, with the first 12 months focused on demonstrating material technical progress, including successful radar absorption testing against agreed benchmarks.

Why developing on production machines matters

Graphene and advanced materials companies often face the same problem.

Something can work well in a laboratory but fail when it is pushed into real-world production. A material that absorbs radar energy effectively in controlled testing may behave differently when it is injection-moulded at commercial temperatures, pressures and volumes.

That is why this agreement is interesting.

By developing the material on Raval’s actual production machines from the beginning, Adisyn gets to test the technology under real manufacturing conditions before it reaches the customer engagement phase.

This gives the company a faster path to developing and testing a real commercial product.

Instead of going through small-scale testing first, then facing another major hurdle around large-scale validation and production, the Raval partnership could help Adisyn move more directly into practical component development, testing and manufacturing readiness.

For investors, that reduces the usual uncertainty around whether the technology can move from concept to commercial product.

It does not remove the technical risk entirely, but it gives Adisyn a much cleaner pathway to proving whether the product can work at scale.

Raval’s quality accreditations also add another layer of credibility. The company meets the IATF automotive quality standard, which is the same type of accreditation required by major automotive groups such as VW and BMW.

That matters because Raval’s processes already meet one of the most demanding quality frameworks in global industry.

For Adisyn, this means the manufacturing baseline is already credible. If the product performs, the company may not need to spend years convincing defence and drone customers that its manufacturing partner can meet high-quality requirements.

The Israel-only scope and the larger global opportunity

Investors also need to understand the limits of the agreement.

The proposed JV would receive manufacturing exclusivity only in Israel under a definitive agreement. The MOU does not include optional rights in any other jurisdiction. That means this is not yet a global manufacturing deal. However, Israel is still a meaningful starting point.

The Israeli Ministry of Defence is an identified target customer, and Israel is one of the world’s most important drone and defence technology hubs. It also has export pathways to allied nations across NATO and the Middle East. That gives the agreement strategic weight.

If Adisyn can prove the technology in Israel, the larger opportunity is not just the Israeli market. The larger question is what this technology could be worth if defence companies begin to see graphene radar absorption as a valuable capability across drones, UAVs and other military assets. That is where the investment case becomes more interesting.

2D Radar may also apply for non-dilutive grant funding from MAFAT or the Israeli Innovation Authority. If successful, that could help offset part of the development cost during the collaboration window without diluting shareholders.

For an early-stage company like Adisyn, that matters. Funding technical development without constantly raising equity can make a major difference to the risk-reward profile.

What could Adisyn be worth if the stars align?

As we discussed HERE, a credible acquisition value for the defence-only vertical of Adisyn’s IP, assuming it gets through demonstration, validation and signs at least one defence contract, could potentially sit in the US$300m (A$400m) to US$800m (A$1.1bn) range.

At the upper end of this pretty wide range, if a defence company concluded that owning this technology outright was strategically necessary (a not-unreasonable view given the geopolitics), you could see numbers above US$1bn (A$1.4bn).

For a company with a current market cap of around A$330m, that is the kind of upside that makes microcaps interesting, in our view.

Even an acquisition price at the lower end of the range, say A$400m, would translate to roughly A$0.34 per AI1 share at the current share count of almost 1.2bn shares (fully diluted). Add that to the current share price, and it does not require the semiconductor story to do anything beyond what is already in the Pitt Street Research price target. You’d be looking at a target of around 63 cents per share.

Keep in mind, these are just scenarios and a lot still needs to happen before Adisyn may be in a position to monetise its graphene coating technology. So, be mindful of that when considering an investment in AI1.

More coverage of ASX-listed defence and technology names is available at stocksdownunder.

Disclosure: Stocks Down Under/Pitt Street Research director(s) own shares in DVL.